Last reviewed · How we verify

Saline solution, 0.6% — Competitive Intelligence Brief

Saline solution, 0.6% (Saline solution, 0.6%) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent / Ophthalmic decongestant. Area: Ophthalmology.

marketed Osmotic agent / Ophthalmic decongestant Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Saline solution, 0.6% (Saline solution, 0.6%) — Novaliq GmbH. Hypotonic saline solution (0.6%) reduces corneal edema and improves corneal clarity by osmotically drawing fluid from swollen corneal tissue.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Saline solution, 0.6% TARGET Saline solution, 0.6% Novaliq GmbH marketed Osmotic agent / Ophthalmic decongestant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent / Ophthalmic decongestant class)

  1. Novaliq GmbH · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Saline solution, 0.6% — Competitive Intelligence Brief. https://druglandscape.com/ci/saline-solution-0-6. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: